Journal ArticleDOI
Cardiovascular Comorbidity in COPD: Systematic Literature Review
TLDR
Available observational data support the hypothesis that COPD is associated with an increased risk of CVD, and two studies found a relationship between the severity of airflow limitation and CVD risk.About:
This article is published in Chest.The article was published on 2013-10-01. It has received 251 citations till now. The article focuses on the topics: Rate ratio & COPD.read more
Citations
More filters
Journal ArticleDOI
Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD.
TL;DR: In 2017, glycopyrrolate (GLY) delivered via the eFlow® closed system (CS) nebulizer (nebulized GLY; 25µg twice daily), was approved by the US Food and Drug Administration for maintenance treatment of moderate-to-very-severe COPD as mentioned in this paper.
Journal ArticleDOI
ECG Abnormalities in Patients with Acute Exacerbation of Bronchiectasis and Factors Associated with High Probability of Abnormality.
TL;DR: In this article, the authors defined the most common ECG abnormalities in patients with acute exacerbation of bronchiectasis and studied the correlation between the cardiac disorder and the other risk factors of the exacerbation.
Posted ContentDOI
Cardiometabolic comorbidities and associated patterns of healthcare utilization and quality of life: results from the Study on Global AGEing and Adult Health (SAGE) Wave 2 in Ghana
TL;DR: In this article , the association of different comorbidity combinations with healthcare utilization and quality of life (QoL) was assessed using the World Health Organization (WHO) study on global AGEing and adult health Wave 2 (2015) conducted in Ghana.
Journal ArticleDOI
Limitación al flujo aéreo en pacientes con insuficiencia cardíaca: prevalencia y factores asociados
Aida Muñoz-Ferrer,Laura Rodriguez-Pons,Ignasi Garcia-Olivé,Josep Lupón,Josep Lupón,Marta de Antonio,Mar Domingo,Pedro Moliner,Elisabet Zamora,Elisabet Zamora,Evelyn Santiago,Antoni Bayes-Genis,Antoni Bayes-Genis,Jorge Abad +13 more
TL;DR: The prevalencia of limitacion al flujo aereo en pacientes con IC es elevada, con un importante grado of infradiagnostico.
Journal ArticleDOI
Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation.
Vidar Søyseth,Natalia Kononova,Anke Neukamm,Nils Henrik Holmedahl,Tor-Arne Hagve,Torbjørn Omland,Gunnar Einvik +6 more
TL;DR: In this article, the authors investigated whether acute exacerbation of COPD causes troponin elevation, and they found that higher levels in patients with COPD are associated with higher troponins.
References
More filters
Journal ArticleDOI
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo,Suzanne S. Hurd,Alvar Agusti,Paul W. Jones,Claus Vogelmeier,Antonio Anzueto,Peter J. Barnes,Leonardo M. Fabbri,Fernando J. Martinez,Masaharu Nishimura,Robert A. Stockley,Don D. Sin,Roberto Rodriguez-Roisin +12 more
TL;DR: It is recommended that spirometry is required for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation.
Journal ArticleDOI
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
TL;DR: Reduced lung function is associated with increased levels of systemic inflammatory markers which may have important pathophysiological and therapeutic implications for subjects with stable COPD.
Journal ArticleDOI
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.
TL;DR: Subjects with GOLD stage 3 or 4 COPD had a higher prevalence of diabetes, which contributes to a higher risk of adverse outcomes of mortality and hospitalisations, and subjects with impaired lung function had more comorbid disease.
Journal ArticleDOI
Mortality in COPD: Role of comorbidities.
TL;DR: The current paper reviews the role of comorbidities in chronic obstructive pulmonary disease mortality, the putative underlying pathogenic link between chronic obstructives pulmonary disease and comorbrid conditions (i.e. inflammation), and the tools used to predict Chronic obstructivemonary disease mortality.
Journal ArticleDOI
Systemic effects of chronic obstructive pulmonary disease
TL;DR: In this article, the authors discuss the following systemic effects of chronic obstructive pulmonary disease: 1) systemic inflammation; 2) nutritional abnormalities and weight loss; 3) skeletal muscle dysfunction; 4) other potential systemic effects.